Scientific deep-dive

Does Tricare Cover Weight-Loss Drugs? (2026)

Tricare covers Wegovy, Zepbound and Saxenda for Prime and Select with prior authorization, but not Tricare For Life since August 2025. The 2026 evidence.

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed
12 min read·10 citations

Short version: Tricare, the U.S. military health program, runs its pharmacy benefit through Express Scripts. Weight-loss GLP-1s (Wegovy, Zepbound, Saxenda) plus the oral anti-obesity drugs (Qsymia, Contrave, phentermine) are covered only for beneficiaries on Tricare Prime or Tricare Select (and the premium-based plans), and only after an Express Scripts prior authorization that requires a BMI threshold, a trial of oral weight-loss drugs, and a documented diet-and-exercise attempt.[1][2] As of August 31, 2025, weight-loss drugs are no longer covered for Tricare For Life (TFL) beneficiaries, direct-care-only beneficiaries, and NATO/Partnership-for-Peace beneficiaries — the Defense Health Agency says federal law never authorized it.[3][4] GLP-1s prescribed for type 2 diabetes (Ozempic, Mounjaro, Trulicity, Victoza) remain covered for everyone, including TFL, with prior authorization.[1][5] Because the formulary and PA machinery belong to Express Scripts, see our dedicated guide on does Express Scripts cover weight-loss drugs.

The honest answer

It depends on which Tricare plan you have and on the indication. If you are on Tricare Prime or Tricare Select, weight-loss GLP-1s are covered with a prior authorization that clears a BMI, oral-drug-trial, and diet-and-exercise gate.[2] If you are on Tricare For Life (the Medicare-wraparound plan for retirees 65+), the answer for weight loss is now no — the Defense Health Agency ended that coverage on August 31, 2025, calling the prior coverage “unauthorized” under federal statute.[3][4] Diabetes GLP-1s stay covered for everyone. One more thing that surprises members: weight-loss drugs cannot be filled at military pharmacies — only Tricare Home Delivery or a network retail pharmacy.[6] Always verify with the Tricare Formulary Search tool and Express Scripts before committing.

At a glance

  • Tricare GLP-1 coverage for type 2 diabetes: generally YES with prior authorization, for all eligible plans including Tricare For Life. Ozempic, Mounjaro, Trulicity, and Victoza are covered for the diabetes indication.[1][5]
  • Tricare GLP-1 coverage for weight loss: YES for Tricare Prime and Tricare Select (and premium-based plans) with prior authorization — Wegovy, Zepbound, Saxenda, plus oral Qsymia, Contrave, and phentermine.[1][2]
  • Tricare For Life: NO for weight loss as of August 31, 2025. The Defense Health Agency says federal law does not authorize TFL to cover drugs prescribed for weight loss as the sole or major condition.[3][4]
  • Prior-authorization criteria (weight loss): BMI ≥ 30, OR BMI ≥ 27 with a weight-related condition; a trial of oral weight-loss medications (e.g., Qsymia, Contrave, or their generic components) that failed or cannot be used; and a documented attempt to lose weight through diet and exercise for at least 6 months.[2]
  • Where you can fill them: NOT at military pharmacies (military treatment facilities). Weight-loss drugs are available only through Tricare Home Delivery or a Tricare network retail pharmacy.[6]
  • Pharmacy benefit manager: Express Scripts administers the Tricare pharmacy benefit, the formulary, and the prior-authorization process.[5]
  • Cost when covered: standard Tricare pharmacy cost-shares apply at home delivery or retail; active-duty service members pay $0. If you do not meet the criteria or are on an excluded plan, you pay 100% of the cash price — widely reported near $1,300/month at retail.[1][4]

Tricare runs its pharmacy benefit through Express Scripts

Tricare is the health program of the U.S. Department of Defense, covering active-duty service members, retirees, National Guard and Reserve members, and their families. Its pharmacy benefit is administered by Express Scripts, the same pharmacy benefit manager (PBM) used by many commercial plans. That means the Tricare uniform formulary, prior-authorization adjudication, step-therapy rules, and the network of retail and home-delivery pharmacies all run through Express Scripts rather than through a military office.[5]

The Defense Health Agency (DHA) sets the clinical policy — what counts as medically necessary, which BMI thresholds apply, and which beneficiary categories are statutorily eligible — while Express Scripts operationalizes it. Practically, members interact with the Tricare Formulary Search tool, the Express Scripts member site (militaryrx.express-scripts.com), and the Express Scripts prior-authorization desk (reachable at 877-363-1303).[6] For the broader PBM picture, see our companion guide, does Express Scripts cover weight-loss drugs.

GLP-1 coverage for type 2 diabetes (covered for everyone)

For the type 2 diabetes indication, Tricare covers certain GLP-1 receptor agonists with prior authorization — and this coverage applies to all eligible plans, including Tricare For Life. The agents named on the Tricare pharmacy benefit for diabetes:

  • Ozempic (semaglutide) — once-weekly injection, FDA-approved for T2D and cardiovascular risk reduction in T2D with established CVD.
  • Mounjaro (tirzepatide) — once-weekly dual GIP/GLP-1 receptor agonist, FDA-approved for T2D.
  • Trulicity (dulaglutide) — once-weekly GLP-1, FDA-approved for T2D plus CV risk reduction. Tricare assigns Trulicity a lower copayment tier than some peers.[1]
  • Victoza (liraglutide) — daily GLP-1, FDA-approved for T2D.

Because the drug is being used for diabetes — not weight loss — the diabetes pathway is unaffected by the August 2025 weight-loss exclusion. DHA was explicit that Tricare “still covers certain drugs (such as Ozempic, Mounjaro, Trulicity, and Victoza) for all patients to treat diabetes when medically necessary,” with copays and cost-shares unchanged.[4] A T2D prior authorization typically documents the diabetes diagnosis and that the drug is being prescribed for blood-sugar control. For drug-level detail, see our semaglutide drug page and tirzepatide drug page.

GLP-1 coverage for weight loss (Prime and Select only, strict PA)

Tricare does cover weight-loss drugs — an important contrast with Medicare, which is statutorily barred from doing so — but only for the right plans and only after a multi-part prior authorization. The covered anti-obesity medications are the three injectable GLP-1s plus the oral agents:

  • Wegovy (semaglutide 2.4 mg) — once-weekly injection; in 2026 also available as an oral pill (Tricare coverage criteria for the oral form were still being established at the time of writing).
  • Zepbound (tirzepatide) — once-weekly injection for chronic weight management.
  • Saxenda (liraglutide 3.0 mg) — daily injection; Tricare requires a medical-necessity form specifically for Saxenda.[1]
  • Oral anti-obesity drugs: Qsymia, Contrave, and phentermine are also covered with prior authorization.[5]

Which plans get weight-loss coverage: Tricare Prime, Tricare Prime Remote, the US Family Health Plan, Tricare Select, and the premium-based plans — Tricare Young Adult, Tricare Reserve Select, Tricare Retired Reserve, and the Continued Health Care Benefit Program (CHCBP).[1] Excluded from weight-loss coverage: Tricare For Life, direct-care-only beneficiaries, and NATO/Partnership-for-Peace beneficiaries.[6]

When the plan is eligible, the Express Scripts prior authorization requires documentation of all of the following:[2]

  1. A BMI of 30 or higher, OR a BMI of 27 or higher with a weight-related health condition.
  2. A trial of oral weight-loss medications — such as Qsymia, Contrave, or one of their generic components — that did not work, or a documented medical reason you cannot take them.
  3. A documented, unsuccessful attempt to lose weight through diet and exercise for at least 6 months.
  4. A prescription from a Tricare network provider and a completed Express Scripts prior-authorization form (a separate medical-necessity form is required for Saxenda).[1]

Express Scripts typically returns a PA decision roughly 10 days after it receives a complete form, and an initial approval generally runs for 12 months.[2] If you had an approved PA before August 31, 2025 but are now on an excluded plan, that authorization no longer guarantees coverage — you would pay the full cash price. For the underlying weight-loss magnitudes that anchor those PA thresholds, compare options on our best semaglutide providers and best tirzepatide providers pages.

The August 31, 2025 Tricare For Life change

The single biggest 2025 development is that Tricare For Life stopped covering weight-loss drugs on August 31, 2025. TFL is the Medicare-wraparound plan that covers Medicare-eligible military retirees (typically age 65+) and their Medicare-eligible family members. The Defense Health Agency framed the change not as a benefit cut by choice but as a correction: DHA said Tricare had been “providing coverage for weight loss medications to beneficiaries who were not eligible under federal statute,” and that it was ending “unauthorized coverage.”[4]

The legal logic is that TFL operates under a different statutory and regulatory framework than Tricare Prime and Tricare Select. As DHA put it, “federal law doesn’t authorize TFL to cover weight loss medications when prescribed for weight loss as the sole or major condition” — and the governing regulation excludes medications intended to control or reduce weight regardless of co-existing conditions.[3] DHA Chief Medical Officer Dr. Paul Cordts urged beneficiaries to understand “how — and why — Tricare covers these drugs, based on your condition and status.”[4]

The drugs affected for TFL are Wegovy, Zepbound, Saxenda, Qsymia, phentermine, and Contrave when used for weight loss.[4] Three things to keep in mind:

  • Diabetes GLP-1s are unaffected. TFL beneficiaries keep coverage of Ozempic, Mounjaro, Trulicity, and Victoza for type 2 diabetes when medically necessary and PA criteria are met.[4]
  • A pre-existing PA does not survive the change. TFL members who had an active weight-loss PA before August 31, 2025 lost coverage on that date regardless.[6]
  • The change is statutory, not formulary tinkering. Because it rests on federal law for TFL specifically, it is not the kind of thing an appeal or a doctor’s letter can reverse for the weight-loss indication.[3]

Where you can fill weight-loss drugs — not at the base pharmacy

A point that catches many members off guard: even when your plan covers a weight-loss GLP-1, you cannot fill it at a military pharmacy (a military treatment facility, or MTF). Weight-loss drugs are available only through:[6]

  • Tricare Home Delivery (the Express Scripts mail-order pharmacy) — usually the lowest cost-share for a 90-day supply.
  • A Tricare network retail pharmacy — find one via esrx.com/findapharmacy.

Diabetes GLP-1s, by contrast, can still be obtained at military pharmacies subject to local availability. Standard Tricare pharmacy cost-shares apply at home delivery and retail; active-duty service members pay $0 at network retail and home delivery. If you are on an excluded plan or do not meet the PA criteria, you pay the full price — reporting around the TFL change cited retail cash costs near $1,300/month.[4] For comparison shopping while uncovered, our best semaglutide providers page tracks cash and telehealth pricing.

Magnitude comparison

Typical monthly out-of-pocket cost for weight-loss GLP-1s by Tricare pathway. Active-duty members pay $0 at network retail or home delivery; other Prime/Select members pay standard pharmacy cost-shares once a prior authorization is approved. Tricare For Life members and anyone who fails the PA pay 100% of the cash price, widely reported near $1,300/month at retail. Cash floors reflect 2026 self-pay vial and oral-GLP-1 list prices.[1][4][6]

  • Active-duty — network retail or home delivery0 $/mo
    PA still required
  • Prime/Select member — standard pharmacy cost-share38 $/mo
    typical 90-day home-delivery tier
  • New oral GLP-1 cash floor (Wegovy pill, lowest dose)149 $/mo
    2026 self-pay list price
  • LillyDirect Self Pay vial — 7.5 mg therapeutic499 $/mo
    if uncovered
  • Tricare For Life — weight-loss indication (since Aug 2025)1300 $/mo
    no coverage; pay cash
Typical monthly out-of-pocket cost for weight-loss GLP-1s by Tricare pathway. Active-duty members pay $0 at network retail or home delivery; other Prime/Select members pay standard pharmacy cost-shares once a prior authorization is approved. Tricare For Life members and anyone who fails the PA pay 100% of the cash price, widely reported near $1,300/month at retail. Cash floors reflect 2026 self-pay vial and oral-GLP-1 list prices.

How to find out if YOUR Tricare plan covers Wegovy or Zepbound

Four reliable ways, in order from fastest to most authoritative:

  1. Confirm which Tricare plan you have. Weight-loss coverage hinges on plan type: Prime or Select (and premium-based plans) qualify; Tricare For Life, direct-care-only, and NATO/PfP do not.[1][6] Your plan is listed in milConnect / the Beneficiary Web Enrollment system.
  2. Use the Tricare Formulary Search tool. Search “Wegovy” or “Zepbound” on militaryrx.express-scripts.com to see formulary status, prior-authorization requirements, quantity limits, and the cost-share tier for your benefit.[5]
  3. Call Express Scripts at 877-363-1303. Ask specifically: “On my Tricare plan, is Wegovy/Zepbound covered for weight loss, what are the PA criteria, and where can I fill it?” They handle the clinical authorization.[6]
  4. Have your Tricare network provider start the PA. Because approval requires documented BMI, a failed oral-drug trial, and a 6-month diet-and-exercise attempt, your provider gathers that record and submits the Express Scripts prior-authorization (plus the Saxenda medical-necessity form, if relevant).[1][2]

Prior authorization and the limits of appeals

Because the benefit runs through Express Scripts, the weight-loss PA process is the PBM’s. The typical flow:

  1. Your Tricare network prescriber submits a prior-authorization request to Express Scripts documenting BMI, the weight-related condition (if BMI is 27–29.9), the failed/contraindicated oral weight-loss-drug trial, and the 6-month diet-and-exercise attempt.[2]
  2. Express Scripts adjudicates against DHA clinical criteria; a complete form is typically decided within about 10 days, and an approval runs ~12 months.[2]
  3. If the PA is denied for a Prime/Select member because criteria were not met, you can resubmit with additional documentation or pursue Tricare’s pharmacy appeal process through Express Scripts.
  4. If you are on Tricare For Life and the denial is the weight-loss-indication exclusion, that is a statutory bar — an appeal will not change it for weight loss. The viable moves are a diabetes indication (if clinically appropriate), switching to an eligible plan if you qualify, or paying cash.[3][4]

For the operational playbook on appealing dropped coverage across any payer, see our GLP-1 insurance dropped-coverage appeal playbook. For how Tricare compares to a large commercial PBM book of business, see does Cigna cover weight-loss drugs and the broader GLP-1 insurance coverage across Medicare, Medicaid, and commercial plans.

If Tricare denies or excludes — what actually works

Ranked by practicality, the moves while you appeal or if your plan permanently excludes weight-loss drugs:

  • Use the diabetes pathway if it applies. If you have type 2 diabetes, Ozempic, Mounjaro, Trulicity, or Victoza remain covered for everyone — including Tricare For Life — with a diabetes PA.[4]
  • Switch to an eligible Tricare plan if you can. Because weight-loss coverage is tied to Prime/Select eligibility, a member who can move to an eligible plan may regain access. TFL beneficiaries generally cannot, since TFL eligibility follows Medicare status.[3]
  • Complete the oral-drug step first. The PA requires a documented oral weight-loss-drug trial (Qsymia, Contrave, or generics) — starting that trial early both satisfies the requirement and is itself a covered, lower-cost option.[2]
  • Cash-pay oral GLP-1s and self-pay vials. 2026 launches of the Wegovy pill start near $149/month for the lowest dose; LillyDirect Self Pay vials run roughly $299–$699/month by dose. Compounded tirzepatide/semaglutide via verified 503A telehealth is another lower-cost route, though it is not brand Wegovy/Zepbound and quality varies.[1]
  • Document a comorbidity to clear the BMI 27 threshold. For Prime/Select members near the line, a recorded weight-related condition (e.g., hypertension, dyslipidemia) opens the BMI ≥ 27 pathway and strengthens the PA.[2]

Verdict — what most Tricare members should expect

For the median Tricare member asking does Tricare cover weight-loss drugs, the answer splits cleanly by plan and indication:

  1. Type 2 diabetes GLP-1s (Ozempic, Mounjaro, Trulicity, Victoza): YES for everyone, all plans including Tricare For Life, with prior authorization.[4]
  2. Weight-loss drugs on Prime or Select (Wegovy, Zepbound, Saxenda, Qsymia, Contrave, phentermine): YES with a prior authorization that requires BMI ≥ 30 (or ≥ 27 with a comorbidity), a failed oral-drug trial, and a 6-month diet-and-exercise attempt.[2]
  3. Weight-loss drugs on Tricare For Life: NO since August 31, 2025 — a statutory exclusion DHA says it had no authority to cover.[3][4]
  4. Where to fill: home delivery or network retail only — never a military pharmacy — with active-duty members paying $0 and others paying standard cost-shares once approved.[6]

The headline caveat: Tricare is more generous than Medicare on weight-loss drugs for working-age members and families on Prime/Select, but the August 2025 TFL change is a reminder that this is a statutorily governed benefit, not a guaranteed one — and that the cheapest covered path always runs through the Express Scripts prior authorization, home delivery, and (for the uncovered) the diabetes indication or cash-pay options.

Disclaimer

This article is informational and does not constitute medical, financial, or legal advice. Tricare’s pharmacy benefit is administered by Express Scripts under Defense Health Agency policy, and weight-loss-drug coverage depends on your plan type, your clinical eligibility, and federal statute — the authoritative sources for your situation are the Tricare Formulary Search tool, Express Scripts (877-363-1303), and your Tricare network provider. Quoted PA criteria, plan eligibility, cost-shares, and dates are sourced to the primary-source documents cited below and were verified 2026-06-04; payer policies change frequently. Always verify with your specific plan before committing to a treatment plan or paying out-of-pocket for a denial that may be appealable.

Further reading

References

  1. 1.Defense Health Agency / TRICARE. Does TRICARE cover Wegovy, Ozempic, and Mounjaro? — TRICARE covers Wegovy, Saxenda, and Zepbound for weight management for beneficiaries with TRICARE Prime, Prime Remote, US Family Health Plan, TRICARE Select, Young Adult, Reserve Select, Retired Reserve, and CHCBP, with prior authorization (and a medical-necessity form for Saxenda); NOT covered for TRICARE For Life or direct-care-only. Diabetes GLP-1s Trulicity, Ozempic, Victoza, and Mounjaro covered with prior authorization. Verify via the TRICARE Formulary Search tool. tricare.mil/FAQs/Pharmacy/PharmProg_Wegovy. 2025.
  2. 2.Defense Health Agency / TRICARE. Weight Loss Products / TRICARE Coverage of Weight Loss Medications — prior-authorization clinical criteria: BMI ≥ 30, or BMI ≥ 27 with a weight-related health issue; a trial of oral weight-loss medications (Qsymia, Contrave, or generic components) that failed or cannot be used; an unsuccessful attempt to lose weight through diet and exercise for at least 6 months. PA decision typically ~10 days after a complete form; initial approval 12 months. tricare.mil/weightlossproducts. 2025.
  3. 3.Defense Health Agency / TRICARE. Q&A: TRICARE For Life Coverage of Weight Loss Medications — effective August 31, 2025, TFL no longer covers weight-loss medications. Federal law does not authorize TFL to cover weight-loss medications when prescribed for weight loss as the sole or major condition; the governing regulation excludes medications intended to control or reduce weight regardless of co-existing conditions. Diabetes GLP-1s remain covered for TFL. newsroom.tricare.mil/News/TRICARE-News/Article/4297241. 2025.
  4. 4.Schogol J. / Military Times. TRICARE to end coverage of weight-loss meds for some military retirees — effective August 31, 2025 for Medicare-eligible retirees and family members on TRICARE For Life. DHA characterized prior coverage as 'unauthorized,' provided to beneficiaries not eligible under federal statute; diabetes GLP-1 coverage (Trulicity, Ozempic, Mounjaro, Victoza) continues; DHA Chief Medical Officer Dr. Paul Cordts comment; retail cash cost reported near $1,300/month. militarytimes.com/pay-benefits/military-benefits/health-care/2025/08/27. 2025.
  5. 5.Express Scripts (TRICARE Pharmacy Program). Are GLP-1 and weight-loss medications covered through the TRICARE pharmacy benefit? — diabetes GLP-1s (Trulicity, Ozempic, Mounjaro, Victoza) covered with prior authorization; weight-loss drugs (Wegovy, Zepbound, Contrave, Qsymia, phentermine) covered for TRICARE Prime and Select with prior authorization; as of August 31, 2025 weight-loss coverage no longer available for non-Prime/non-Select beneficiaries. militaryrx.express-scripts.com/faq/are-glucagon-peptide-1-glp-1-and-weight-loss-medications-covered-through-tricare-pharmacy. 2025.
  6. 6.Express Scripts (TRICARE Pharmacy Program). GLP-1 Medications (Diabetes and Weight Management) — fill weight-loss drugs at TRICARE Home Delivery or a network retail pharmacy (esrx.com/findapharmacy), NOT at a military pharmacy; weight-loss coverage limited to TRICARE Prime and Select; Express Scripts prior-authorization desk 877-363-1303. militaryrx.express-scripts.com/GLP-1-medications-diabetes-weight-management. 2025.
  7. 7.U.S. Air Force Benefits (republishing TRICARE News). TRICARE Coverage of Weight Loss Medications: What To Know — confirms covered drugs (Saxenda, Wegovy, Zepbound, Qsymia, phentermine, Contrave), eligible plans (Prime/Select and premium-based), exclusion of TRICARE For Life and direct-care-only, and that existing cost-shares for covered members were unchanged; controls effective August 31, 2025 with prior authorizations becoming invalid unless resubmitted. myairforcebenefits.us.af.mil/TRICARE-Coverage-of-Weight-Loss-Medications-What-To-Know. 2025.
  8. 8.Novo Nordisk. Wegovy (semaglutide) injection — Highlights of Prescribing Information. Indications: chronic weight management in adults and pediatric patients aged 12+ with obesity; cardiovascular risk reduction in adults with established CVD and overweight/obesity. dailymed.nlm.nih.gov SetID ee06186f-2aa3-4990-a760-757579d8f77b. 2026.
  9. 9.Eli Lilly. Zepbound (tirzepatide) injection — Highlights of Prescribing Information. Indications: chronic weight management; moderate-to-severe obstructive sleep apnea in adults with obesity (12/20/2024 expansion). dailymed.nlm.nih.gov SetID 487cd7e7-434c-4925-99fa-aa80b1cc776b. 2026.
  10. 10.Centers for Medicare & Medicaid Services (CMS). Social Security Act §1860D-2(e)(2)(A) — Medicare Part D excluded drugs: agents when used for the symptomatic relief of cough and colds, anorexia, weight loss, or weight gain. Context for why TRICARE For Life, a Medicare-wraparound plan, faces a weight-loss-drug exclusion that Prime/Select do not. ssa.gov/OP_Home/ssact/title18/1860D-2.htm. 2024.

Glossary references

Key terms in this article, linked to their canonical definitions.

Where to get tirzepatide (Mounjaro / Zepbound): vetted providers

Vetted telehealth providers that prescribe online, ranked by our editorial score. We compare pricing, form, and states served.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

8.1

Strut Health

7.9

Get Thin MD